| Q40838697 | A biologically motivated partitioning of mortality |
| Q36691416 | A review of health care models for coronary heart disease interventions |
| Q36987220 | Activities of daily living and cardiovascular complications following elective, noncardiac surgery |
| Q33754385 | Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. |
| Q77340451 | Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan |
| Q40886145 | Antiarrhythmic therapies for the prevention of sudden cardiac death |
| Q37875140 | Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events |
| Q37308578 | Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes |
| Q35827489 | Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study |
| Q37097924 | Behavioral health: Treatment and prevention of chronic disease and the implications for social work practice |
| Q35091945 | Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention |
| Q40240003 | Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland? |
| Q36593266 | Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease |
| Q36697592 | Cardiovascular Disease Screening By Community Health Workers Can Be Cost-Effective In Low-Resource Countries |
| Q81551074 | Cardiovascular disease and associated risk factors in Cuba: prospects for prevention and control |
| Q53224795 | Cardiovascular disease and global health equity: lessons from tuberculosis control then and now. |
| Q35372621 | Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions |
| Q34032682 | Cardiovascular disease: risk factors in older Canadians. |
| Q41697387 | Cardiovascular diseases in women |
| Q33623117 | Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America |
| Q37073597 | Cardiovascular risk reduction via telehealth: a feasibility study |
| Q26861748 | Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States |
| Q50651261 | Changing patterns of coronary heart disease in the hunter region of New South Wales, Australia. |
| Q46565387 | Characteristics associated with differences in reported versus measured total cholesterol among male physicians |
| Q37716571 | Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts |
| Q33843633 | Chronic infection and coronary artery disease |
| Q39670517 | Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). |
| Q79116769 | Comparing multifactorial lifestyle interventions and stress management in coronary risk reduction |
| Q28217496 | Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000 |
| Q46103481 | Comparison of Markov model and discrete-event simulation techniques for HIV. |
| Q42321695 | Comparison of models for predicting outcomes in patients with coronary artery disease focusing on microsimulation. |
| Q33633383 | Continued improvement of cardiovascular mortality in Hungary--impact of increased cardio-metabolic prescriptions |
| Q35371795 | Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 |
| Q27012592 | Contributions of risk factors and medical care to cardiovascular mortality trends |
| Q73639657 | Controlling the ischemic heart disease epidemic: strategies for the 21st century |
| Q35115881 | Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model |
| Q37614187 | Coronary heart disease attributable to passive smoking: CHD Policy Model |
| Q81461875 | Coronary heart disease deaths and decreased smoking prevalence in Massachusetts, 1993-2003 |
| Q28200183 | Coronary heart disease policy models: a systematic review |
| Q51935762 | Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada. |
| Q34733821 | Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors |
| Q35696678 | Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. |
| Q35002144 | Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. |
| Q36248014 | Depressive symptoms are associated with incident coronary heart disease or revascularization among blacks but not among whites in the Reasons for Geographical and Racial Differences in Stroke study. |
| Q35644444 | Deprivation and mortality at the town level in Busan, Korea: an ecological study |
| Q34743755 | Do race and gender influence the use of invasive procedures? |
| Q42579997 | Does modern medicine increase life-expectancy: Quest for the Moon Rabbit? |
| Q33791827 | Ecological studies are a poor means of testing aetiological hypotheses |
| Q36610967 | Effect of workplace-visiting nutrition education on anthropometric and clinical measures in male workers |
| Q36002244 | Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial |
| Q39673496 | Effects of the Quebec Heart Health Demonstration Project on adult dietary behaviours |
| Q37342598 | Encouraging trends in acute myocardial infarction survival in the oldest old. |
| Q90041724 | Enter Stage A, Exit Stage D: A Curtain Call for Delay in Heart Failure Prevention |
| Q50088890 | Evaluating the Effectiveness of New York City Health Policy Initiatives in Reducing Cardiovascular Disease Mortality, 1990-2011. |
| Q43664387 | Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. |
| Q44865511 | Evidence of increasing coronary heart disease mortality among black men of lower social class |
| Q84242169 | Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000 |
| Q36933684 | Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. |
| Q24804642 | Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need |
| Q33775173 | Fatality outside hospital from acute coronary events in three British health districts, 1994-5. United Kingdom Heart Attack Study Collaborative Group |
| Q35040523 | First myocardial infarction in a Dutch general practice population: trends in incidence from 1975-2003 |
| Q37682478 | Fixed drug combination in hypertension and hyperlipidaemia in the developing world. |
| Q84734674 | Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model |
| Q35619428 | Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies |
| Q34186893 | Heart health in older adults. Import of heart disease and opportunities for maintaining cardiac health |
| Q35029504 | How does gender influence the recognition of cardiovascular risk and adherence to self-care recommendations?: A study in Polish primary care. |
| Q35558913 | How good is the Prevent model for estimating the health benefits of prevention? |
| Q34722769 | Hypertension knowledge, awareness, and attitudes in a hypertensive population |
| Q73471541 | Hypothesis: the recent decline in coronary heart disease mortality--mainly a shift from fatal to non-fatal events? |
| Q45330365 | Improving care after myocardial infarction using a 2-year internet-delivered intervention: the Department of Veterans Affairs myocardial infarction-plus cluster-randomized trial |
| Q24795387 | Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress |
| Q33871329 | Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease? |
| Q35381535 | Is the prevalence of coronary heart disease falling in British men? |
| Q73846164 | Issues in equalizing Medicare expenditures--the devil is in the details |
| Q34032688 | Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. |
| Q44520744 | Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? |
| Q61192550 | Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000 |
| Q37833906 | Lipid parameters for measuring risk of cardiovascular disease |
| Q95824867 | Local increases in coronary heart disease mortality among blacks and whites in the United States, 1985-1995 |
| Q37620117 | Long-term trends of inequalities in mortality in 6 European countries |
| Q35559096 | Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time |
| Q37458880 | Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. |
| Q77120974 | Management of the hypertensive patient who smokes |
| Q33853043 | Markers of inflammation as predictors in cardiovascular disease |
| Q37046019 | Measuring the health of nations: analysis of mortality amenable to health care |
| Q77925142 | Medical education--communicating best practice |
| Q38808082 | Million Hearts: Description of the National Surveillance and Modeling Methodology Used to Monitor the Number of Cardiovascular Events Prevented During 2012-2016. |
| Q73516100 | Missed opportunities to impact fast response to AMI symptoms |
| Q33998019 | Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention |
| Q35404687 | Non-communicable disease mortality rates using the verbal autopsy in a cohort of middle aged and older populations in Beirut during wartime, 1983-93. |
| Q31158135 | Obesity prevention: the role of policies, laws and regulations |
| Q39580940 | Obesity, diabetes, hypertension, and tobacco consumption in an urban adult Mexican population |
| Q34158844 | Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data |
| Q28484624 | Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study |
| Q37212063 | Population health: challenges for science and society |
| Q33786492 | Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors |
| Q34032695 | Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992 |
| Q37098508 | Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective? |
| Q43242381 | Preventing coronary heart disease |
| Q34129526 | Prevention of cardiovascular disease and diabetes: lessons from the Malmö Preventive Project |
| Q38075808 | Prevention of coronary artery disease: recent advances in the management of hypertension |
| Q34009185 | Primary cancer prevention trials |
| Q36591044 | Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes |
| Q77096713 | QRS Score: a composite index of exercise-induced changes in the Q, R, and S waves during exercise stress testing in patients with ischemic heart disease |
| Q37226642 | Quantifying options for reducing coronary heart disease mortality by 2020 |
| Q78085319 | Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996 |
| Q33791941 | Recent advances. General medicine |
| Q36635487 | Recent developments in decision-analytic modelling for economic evaluation |
| Q38019423 | Regression of atherosclerosis |
| Q39539817 | Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. |
| Q42759683 | Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind |
| Q34228850 | Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial |
| Q36755859 | Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study |
| Q37160346 | Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study |
| Q34135254 | Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice |
| Q35411223 | Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels |
| Q36861254 | Sudden unexpected cardiac death as a function of time since the detection of electrocardiographic and clinical risk factors in apparently healthy men: the Manitoba Follow-Up Study, 1948 to 2004. |
| Q33821081 | Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study) |
| Q53583140 | The assault on specialty medicine and the modern surgeon. |
| Q35547111 | The challenges of treating peripheral arterial disease |
| Q47831748 | The comparative medical costs of atherothrombotic disease in European countries |
| Q36295307 | The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers |
| Q36925939 | The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis |
| Q33387452 | The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China |
| Q33401729 | The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. |
| Q73877878 | The impact of high-risk patients on the results of clinical trials |
| Q33514949 | The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study |
| Q46510248 | The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies |
| Q33975925 | Transitional changes in health-disease: why so many puzzling epidemiological situations? |
| Q36357988 | Translating from the rivers of Babylon to the coronary bloodstream |
| Q35322312 | Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys |
| Q35999277 | Trends in cardiovascular disease biomarkers and their socioeconomic patterning among adults in the Scottish population 1995 to 2009: cross-sectional surveys |
| Q35580204 | Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world |
| Q44504989 | Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. |
| Q53083519 | Triangulating on success: innovation, public health, medical care, and cause-specific US mortality rates over a half century (1950-2000). |
| Q34127393 | Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications |
| Q37391696 | Urban-rural differences in coronary heart disease mortality in the United States: 1999-2009. |
| Q57387592 | Urban-rural inequalities in ischemic heart disease in Scotland, 1981-1999 |
| Q28744274 | Validation of population-based disease simulation models: a review of concepts and methods |
| Q36047855 | Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK). |
| Q93342656 | World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study |